0 Comments
0 Shares
199 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Generic Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Generic Drug Market Size and Share Forecast Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical...0 Comments 0 Shares 266 Views 0 Reviews
-
Generic Drug market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis" According to the latest report published by Data Bridge Market Research, the Generic Drug Market Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value,...0 Comments 0 Shares 88 Views 0 Reviews
-
Generic Pharmaceutical Market Trends: Digital Healthcare, Biosimilars & Affordable Drug Manufacturing Growth (2025–2033)Generic Pharmaceutical Market: Digital Pharma Innovation, Biosimilars Expansion & Cost-Effective Healthcare Solutions (2025–2033) Written By Shubham Senior Pharmaceutical & Healthcare Technology Market Research Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a healthcare and pharmaceutical industry analyst specializing in generic medicines, biosimilars, digital...0 Comments 0 Shares 104 Views 0 Reviews
-
Global Erlotinib Generics Market Growth Driven by Rising NSCLC Cases and Expanding Generic Drug Access to 2034According to a new report from Intel Market Research, the global Erlotinib Generics market was valued at USD 682.4 million in 2025 and is projected to reach USD 1,189.3 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer, increasing healthcare expenditure in emerging...0 Comments 0 Shares 167 Views 0 Reviews
